What We Know So Far About ECG for Pancreatic Pseudocysts

被引:0
|
作者
Kluszczyk, Paulina [1 ]
Jablonska, Beata [2 ]
Serafin, Michal [1 ]
Tobiasz, Aleksandra [1 ]
Kowalczyk, Tomasz [1 ]
Maslanka, Sebastian [1 ]
Chapula, Mateusz [3 ]
Wosiewicz, Piotr [3 ]
Mrowiec, Slawomir [2 ]
机构
[1] Med Univ Silesia, Fac Med Sci Katowice, Dept Digest Tract Surg, Student Sci Soc, Medykow 14 St, PL-40752 Katowice, Poland
[2] Med Univ Silesia, Fac Med Sci Katowice, Dept Digest Tract Surg, Medykow 14 St, PL-40752 Katowice, Poland
[3] Med Univ Silesia, Fac Med Sci Katowice, Dept Gastroenterol & Hepatol, Medykow 14 St, PL-40752 Katowice, Poland
来源
LIFE-BASEL | 2024年 / 14卷 / 11期
关键词
post-inflammatory pancreatic cysts; endoscopic internal drainage; endoscopic cystogastrostomy; GUIDED TRANSMURAL DRAINAGE; EXPANDING METAL STENTS; WALLED-OFF NECROSIS; SURGICAL-TREATMENT; ENDOSCOPIC TREATMENT; FLUID COLLECTIONS; CLINICAL-OUTCOMES; PLASTIC STENTS; MANAGEMENT; EFFICACY;
D O I
10.3390/life14111419
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Endoscopic cysto-gastrostomy (ECG) has become the treatment of choice for pancreatic pseudocysts (PPCs). Endoscopic drainage of PPCs requires the creation of an anastomosis between the lumen of the PPCs and the lumen of the gastrointestinal tract. Various types of stents are used for this purpose. The aim of the study is to compare the indications, quantity, and results of using double pigtail plastic stents (DPPSs) and lumen-apposing fully covered metal stents (LAMSs) in ECG. Methods: A retrospective analysis was conducted of 39 patients (24 men, 15 women) treated for PPCs in the Department of Digestive Tract Surgery and the Department of Gastroenterology and Hepatology between October 2018 and February 2023. The mean age of patients was 51.13 (28-77). Data about etiology, cyst diameter, type, and complications of the stents were collected. Results: DPPSs were placed in smaller cysts (108 vs. 140 millimeters, p = 0.04) and were maintained for a longer duration compared to LAMSs (106 vs. 34 days, p = 0.001). Cyst recurrence was reported less frequently in patients with a LAMS (0 (0%) vs. 4 (19.05%), p = 0.05) and the therapeutic success was non-significantly higher in the LAMS group compared to the DPPS group (100% vs. 85.71%), p = 0.095. Conclusions: Both DPPSs and LAMSs are characterized by high therapeutic success and low complication rates in patients undergoing ECG for PPCs.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] China coronavirus: what do we know so far?
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 368 : m308
  • [42] Refractory hypertension: what do we know so far?
    Muxfeldt, Elizabeth Silaid
    Chedier, Bernardo
    JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (03) : 181 - 183
  • [43] Trends in HeartMate 3: What we know so far
    Lanfear, Allison T.
    Hamandi, Mohanad
    Fan, Joy
    DiMaio, J. Michael
    George, Timothy J.
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (01) : 180 - 187
  • [44] Diet in the Treatment of Epilepsy: What We Know So Far
    Verrotti, Alberto
    Iapadre, Giulia
    Di Francesco, Ludovica
    Zagaroli, Luca
    Farello, Giovanni
    NUTRIENTS, 2020, 12 (09) : 1 - 19
  • [45] Mitochondrial cytopathy in adults: What we know so far
    Cohen, BH
    Gold, DR
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2001, 68 (07) : 625 - +
  • [46] Visual snow syndrome: what we know so far
    Puledda, Francesca
    Schankin, Christoph
    Digre, Kathleen
    Goadsby, Peter J.
    CURRENT OPINION IN NEUROLOGY, 2018, 31 (01) : 52 - 58
  • [47] Fire effects on anurans: What we know so far?
    dos Anjos, Amanda Gomes
    Sole, Mirco
    Benchimol, Maira
    FOREST ECOLOGY AND MANAGEMENT, 2021, 495
  • [48] Monkeypox transmission-what we know so far
    Venkatesan, Priya
    LANCET RESPIRATORY MEDICINE, 2022, 10 (11): : E101 - E101
  • [49] Mpox infection in neonates: what we know so far?
    Kumar, Jogender
    Meena, Jitendra
    PAEDIATRICS AND INTERNATIONAL CHILD HEALTH, 2022, 42 (3-4) : 173 - 174
  • [50] Exosomes in Retinoblastoma: What do we know so far?
    Kaliki, Swathi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)